Alembic looks for an arrival in the Bull marketAlembic Ltd. is engaged in the business of pharmaceuticals and real estate. Its core operation is manufacturing and marketing of APIs (active pharmaceutical ingredients) and construction and leasing of corporate & commercial properties. The company is also engaged in research and development in his pharma business. Alembic CMP is 69.20.
Negative aspects of the company are declining annual net profit & FIIs are decreasing stake. Positive aspect of the company is improving cash from operations annual, no debt, zero promoter pledge.
Entry in the stock can be taken after closing above 70. The short-term targets are 76 and 80. The long-term target is 87. Keep a stop loss at 63.
